CEL-SCI (CVM) Stock Chart & Stock Price History $8.92 +0.22 (+2.53%) Closing price 04:00 PM EasternExtended Trading$8.94 +0.02 (+0.17%) As of 07:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CEL-SCI Stock Price Performance The CEL-SCI (CVM) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 73.57%, with a year-to-date return of -25.65%. In the past month, the stock has increased 125.25%, reflecting recent market activity. As of the latest close, CEL-SCI traded at $8.70 with a market cap of $59.87 million and volume of 191,701 shares. Receive CVM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CEL-SCI and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+6.83%1 Month Performance+125.25%3 Month Performance+33.33%Year-To-Date Performance-25.65%1 Year Performance-73.57% CVM Stock Chart for Monday, August, 18, 2025 CVM Chart by TradingView CEL-SCI Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/18/2025$8.70$8.92+2.53%$9.42$8.60234,831 shs$61.39 million08/15/2025$8.14$8.70+6.88%$9.02$7.96191,701 shs$59.87 million08/14/2025$8.35$8.14-2.51%$8.28$7.70188,717 shs$56.02 million08/13/2025$7.63$8.35+9.44%$8.59$7.18414,632 shs$57.47 million08/12/2025$7.03$7.63+8.53%$7.82$6.90206,413 shs$52.51 million08/11/2025$7.44$7.03-5.51%$7.80$6.84206,358 shs$48.38 million08/08/2025$8.23$7.44-9.60%$8.49$7.22418,664 shs$39.59 million08/07/2025$9.14$8.23-9.96%$9.43$8.06252,473 shs$43.79 million08/06/2025$8.94$9.14+2.24%$9.25$8.71217,039 shs$48.63 million08/05/2025$9.25$8.94-3.35%$9.58$8.61308,595 shs$47.57 million Get the Latest News and Ratings for CVM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CEL-SCI and its competitors with MarketBeat's FREE daily newsletter. 08/04/2025$9.45$9.25-2.12%$10.25$8.72353,326 shs$49.22 million08/01/2025$8.18$9.45+15.53%$9.50$7.75521,184 shs$50.28 million07/31/2025$8.58$8.18-4.66%$9.50$8.01481,096 shs$43.53 million07/30/2025$7.15$8.58+20.00%$9.76$7.02864,109 shs$45.65 million07/29/2025$8.66$7.15-17.44%$9.00$7.11755,986 shs$38.05 million07/28/2025$8.20$8.66+5.61%$10.40$8.221.36 million shs$46.08 million07/25/2025$6.85$8.20+19.71%$8.45$6.25941,013 shs$43.63 million07/24/2025$6.29$6.85+8.90%$7.68$6.001.10 million shs$36.45 million07/23/2025$5.27$6.29+19.35%$6.35$5.12651,658 shs$33.47 million07/22/2025$4.35$5.27+21.15%$5.39$4.34693,890 shs$28.04 million07/21/2025$3.96$4.35+9.85%$4.44$3.95718,830 shs$23.15 million07/18/2025$4.17$3.96-5.04%$4.16$3.95417,623 shs$12.01 million07/17/2025$3.85$4.17+8.31%$4.25$3.83757,356 shs$12.64 million Related Companies GENFIT Stock Chart CytomX Therapeutics Stock Chart Eupraxia Pharmaceuticals Stock Chart enGene Stock Chart Puma Biotechnology Stock Chart Editas Medicine Stock Chart China SXT Pharmaceuticals Stock Chart Instil Bio Stock Chart ALT5 Sigma Stock Chart C4 Therapeutics Stock Chart Receive CVM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CEL-SCI and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:CVM) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CEL-SCI Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share CEL-SCI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access